Lack of interleukin‐2 (IL‐2) expression and selective expression of IL‐10 mRNA in human renal cell carcinoma
- 3 November 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 63 (3) , 366-371
- https://doi.org/10.1002/ijc.2910630311
Abstract
Freshly isolated tumor‐infiltrating lymphocytes (TIL) are often functionally deficient. Since one of the key functional parameters of an immune response is the local production of cytokines, we studied the expression of cytokine genes in freshly isolated renal cancer tissue. Using a PCR‐assisted mRNA amplification assay, the constitutive expression of mRNA for 10 different cytokines was assessed in renal cancer tissue. We compared the cytokine mRNA expression in freshly isolated samples of renal carcinomas, renal cancer cell lines established from the tumor samples, peripheral blood mononuclear cells (PBMC) and non‐tumor kidney tissue isolated from the same patients. IL‐10 mRNA expression was detected only in tumor samples, while renal cancer lines, PBMC and non‐tumorous kidney tissues were devoid of this cytokine. One‐third of the tumor samples but none of the normal kidney samples also expressed G‐CSF mRNA. IL‐6, TNF‐α and IFN‐γ mRNA were expressed non‐selectively in tumors, PBMC and normal renal tissue. Expression of IL‐2, IL‐3 and IL‐4 mRNA was not detected in any of the tissues analyzed. Established renal cancer lines exhibited expression of IL‐lα, IL‐6, TNF‐α and GM‐CSF. Culture of tumor‐derived T cells with anti‐CD3 monoclonal antibody (MAb) resulted in expression of IL‐2, IL‐3 and IL‐4 mRNA. In contrast, none of these cytokines was detected in culture with recombinant human IL‐2 alone. Since IL‐10 is known to suppress antigen presentation, these findings have important implications for the possible in vivo role of IL‐10 as a suppressor of local anti‐tumor response.Keywords
This publication has 23 references indexed in Scilit:
- Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.The Journal of Experimental Medicine, 1994
- Interleukin‐10 production by human carcinoma cell lines and its relationship to interleukin‐6 expressionInternational Journal of Cancer, 1993
- Interleukin 10 production correlates with pathology in human Leishmania donovani infections.Journal of Clinical Investigation, 1993
- Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancersCytokine, 1992
- Expression of mRNA for cytokines in tumor‐infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancerInternational Journal of Cancer, 1992
- Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell ClonesScience, 1991
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytesClinical Immunology and Immunopathology, 1991
- The role of IL-10 in crossregulation of TH1 and TH2 responsesImmunology Today, 1991
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985